Shandong Hi-tech Spring Material Technology Co., Ltd.
XSEC:301292 Stock Report
Market Cap: CN¥3.4b
Shandong Hi-tech Spring Material Technology Valuation
Is 301292 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 301292 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 301292's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 301292's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 301292?
Key metric: As 301292 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for 301292. This is calculated by dividing 301292's market cap by their current
revenue.
What is 301292's PS Ratio?
PS Ratio
1x
Sales
CN¥3.40b
Market Cap
CN¥3.39b
301292 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: 301292 is good value based on its Price-To-Sales Ratio (1x) compared to the CN Chemicals industry average (2.4x).
Price to Sales Ratio vs Fair Ratio
What is 301292's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
301292 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
1x
Fair PS Ratio
0.8x
Price-To-Sales vs Fair Ratio: 301292 is expensive based on its Price-To-Sales Ratio (1x) compared to the estimated Fair Price-To-Sales Ratio (0.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.